Literature DB >> 27847358

PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.

Karen E Marshall1, Andrew Hughson1, Sarah Vascellari1, Suzette A Priola1, Akikazu Sakudo2, Takashi Onodera2, Gerald S Baron3.   

Abstract

Glycosylphosphatidylinositol (GPI) anchoring of the prion protein (PrPC) influences PrPC misfolding into the disease-associated isoform, PrPres, as well as prion propagation and infectivity. GPI proteins are found in cholesterol- and sphingolipid-rich membrane regions called rafts. Exchanging the GPI anchor for a nonraft transmembrane sequence redirects PrPC away from rafts. Previous studies showed that nonraft transmembrane PrPC variants resist conversion to PrPres when transfected into scrapie-infected N2a neuroblastoma cells, likely due to segregation of transmembrane PrPC and GPI-anchored PrPres in distinct membrane environments. Thus, it remained unclear whether transmembrane PrPC might convert to PrPres if seeded by an exogenous source of PrPres not associated with host cell rafts and without the potential influence of endogenous expression of GPI-anchored PrPC To further explore these questions, constructs containing either a C-terminal wild-type GPI anchor signal sequence or a nonraft transmembrane sequence containing a flexible linker were expressed in a cell line derived from PrP knockout hippocampal neurons, NpL2. NpL2 cells have physiological similarities to primary neurons, representing a novel and advantageous model for studying transmissible spongiform encephalopathy (TSE) infection. Cells were infected with inocula from multiple prion strains and in different biochemical states (i.e., membrane bound as in brain microsomes from wild-type mice or purified GPI-anchorless amyloid fibrils). Only GPI-anchored PrPC supported persistent PrPres propagation. Our data provide strong evidence that in cell culture GPI anchor-directed membrane association of PrPC is required for persistent PrPres propagation, implicating raft microdomains as a location for conversion. IMPORTANCE: Mechanisms of prion propagation, and what makes them transmissible, are poorly understood. Glycosylphosphatidylinositol (GPI) membrane anchoring of the prion protein (PrPC) directs it to specific regions of cell membranes called rafts. In order to test the importance of the raft environment on prion propagation, we developed a novel model for prion infection where cells expressing either GPI-anchored PrPC or transmembrane-anchored PrPC, which partitions it to a different location, were treated with infectious, misfolded forms of the prion protein, PrPres We show that only GPI-anchored PrPC was able to convert to PrPres and able to serially propagate. The results strongly suggest that GPI anchoring and the localization of PrPC to rafts are crucial to the ability of PrPC to propagate as a prion.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  GPI; NpL2; PrP; neuron; prion; raft; transmembrane; transmissible spongiform encephalopathy

Mesh:

Substances:

Year:  2017        PMID: 27847358      PMCID: PMC5215353          DOI: 10.1128/JVI.01686-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  132 in total

1.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

2.  Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

Authors:  N Naslavsky; R Stein; A Yanai; G Friedlander; A Taraboulos
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

5.  GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.

Authors:  Jonathan O Speare; Danielle K Offerdahl; Aaron Hasenkrug; Aaron B Carmody; Gerald S Baron
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

6.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

7.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

8.  Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.

Authors:  Clive Bate; William Nolan; Alun Williams
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

9.  Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.

Authors:  Sabrina Cronier; Nathalie Gros; M Howard Tattum; Graham S Jackson; Anthony R Clarke; John Collinge; Jonathan D F Wadsworth
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

10.  Host PrP glycosylation: a major factor determining the outcome of prion infection.

Authors:  Nadia L Tuzi; Enrico Cancellotti; Herbert Baybutt; Lorraine Blackford; Barry Bradford; Chris Plinston; Anne Coghill; Patricia Hart; Pedro Piccardo; Rona M Barron; Jean C Manson
Journal:  PLoS Biol       Date:  2008-04-15       Impact factor: 8.029

View more
  7 in total

1.  Endogenous Brain Lipids Inhibit Prion Amyloid Formation In Vitro.

Authors:  Clare E Hoover; Kristen A Davenport; Davin M Henderson; Mark D Zabel; Edward A Hoover
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

Review 2.  Dual role of cellular prion protein in normal host and Alzheimer's disease.

Authors:  Takashi Onodera
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 3.  From Cell Culture to Organoids-Model Systems for Investigating Prion Strain Characteristics.

Authors:  Hailey Pineau; Valerie L Sim
Journal:  Biomolecules       Date:  2021-01-14

4.  GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.

Authors:  Berta Puig; Hermann C Altmeppen; Luise Linsenmeier; Karima Chakroun; Florian Wegwitz; Ulrike K Piontek; Jörg Tatzelt; Clive Bate; Tim Magnus; Markus Glatzel
Journal:  PLoS Pathog       Date:  2019-01-04       Impact factor: 6.823

Review 5.  A New Take on Prion Protein Dynamics in Cellular Trafficking.

Authors:  Rodrigo Nunes Alves; Rebeca Piatniczka Iglesia; Mariana Brandão Prado; Maria Isabel Melo Escobar; Jacqueline Marcia Boccacino; Camila Felix de Lima Fernandes; Bárbara Paranhos Coelho; Ailine Cibele Fortes; Marilene Hohmuth Lopes
Journal:  Int J Mol Sci       Date:  2020-10-20       Impact factor: 5.923

6.  Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture Cells.

Authors:  Takuto Shimizu; Emiko Nogami; Yuka Ito; Kazuo Morikawa; Masaki Nagane; Tadashi Yamashita; Tsuyoshi Ogawa; Fuyuki Kametani; Hisashi Yagi; Naomi Hachiya
Journal:  Neurochem Res       Date:  2021-05-27       Impact factor: 3.996

Review 7.  Propagation and Dissemination Strategies of Transmissible Spongiform Encephalopathy Agents in Mammalian Cells.

Authors:  Stefanie-Elisabeth Heumüller; Annika C Hornberger; Alina S Hebestreit; André Hossinger; Ina M Vorberg
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.